دبي تعزز ريادتها العالمية في مجال العقارات مع عودة معرض العقارات الدولي (IPS) إلى مركز دبي التجاري العالمي في الفترة من 7 إلى 9 سبتمبر 2026
دبي، الإمارات العربية المتحدة, June 10, 2026 (GLOBE NEWSWIRE) — في سوق تتشكل ملامحه على نحو متزايد...
Bitget lance la campagne d’affiliation « Score Your 40% » avec une cagnotte d’un million de dollars
VICTORIA, Seychelles, 10 juin 2026 (GLOBE NEWSWIRE) — Bitget, la plus grande bourse universelle (UEX) au monde, annonce le lancement de « Score Your 40% ». Cette nouvelle campagne d’affiliation internationale, dotée d’une cagnotte d’un million de dollars en USDT, vise à accélérer la croissance de ses affiliés et à...
Bitget CFD Rolls Out Zero-Fee Mode Amid Daily Volume Growth Toward $10B
VICTORIA, Seychelles, June 10, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange (UEX), today announced the launch of Zero-Fee Mode for Bitget CFD, introducing a commission-free account option designed to make CFD trading more flexible, transparent, and accessible.
The launch comes as Bitget CFD continues to scale rapidly, with daily trading volume reaching $8 billion...
Al Tamimi & Company تشارك في حوار عالمي رفيع لاستشراف مستقبل الأطر التنظيمية الجاهزة للمستقبل ضمن أعمال المائدة المستديرة المشتركة بين المنتدى الاقتصادي العالمي وحكومة الإمارات
دبي، الإمارات العربية المتحدة, June 10, 2026 (GLOBE NEWSWIRE) — في تأكيدٍ على التزامها بدعم الحوار...
Bitget Continues Stock Spot Expansion With 30 New Listings Across Leading Market Themes
VICTORIA, Seychelles, June 10, 2026 (GLOBE NEWSWIRE) — Bitget, the world’s largest Universal Exchange, has expanded its stock spot lineup with the listing of 30 new stock spot assets, further widening users’ access to traditional market opportunities under the recent launch of Stock 2.0. The newly listed assets include rNASA, rBMNR, rDIS, rROKU, and rLCID, and were made available...
Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL
PRINCETON, N.J., June 10, 2026 (GLOBE NEWSWIRE) — Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced new data further defining the potential of mogamulizumab in the treatment of relapsed or refractory mycosis fungoides and Sézary syndrome, two subtypes of cutaneous T-cell lymphoma, will be featured at the World Congress of Cutaneous...

